African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12487

Review

Cyclooxygenases: Proliferation and differentiation

Hossein Rastegar1, Hamid Reza Ahmadi Ashtiani2,3,4*, Akram Mirzaei5 and Ali Karimi Bakhshandi6
  1Food and Drug Control Laboratory and Research Center, Tehran, Iran. 2Islamic Azad University, Pharmaceutical sciences branch, Tehran, Iran 3Faculty of medical sciences, Islamic Azad University, Kish International Branch, Kish Island, Iran 4Biochemistry and Nutrition Department of Zanjan University of Medical Sciences, Zanjan, Iran 5Amin Institute of Higher Education, Fooladshahr, Isfahan, Iran. 6Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Email: [email protected]

  •  Accepted: 03 August 2012
  •  Published: 08 November 2012

Abstract

 

Prostaglandins are formed from arachidonic acid by the action of cyclooxygenase and subsequent downstream synthetases. Mainly two cyclooxygenase isoforms have been identified which are now known as cyclooxygenase-1 and cyclooxygenase-2. Both iso-enzymes transform arachidonic acid to prostaglandins, but differ in their distribution and their physiological roles. The two isoenzymes are similar in protein structure but are produced by divergent genes and have different biological functions. Cyclooxygenase-1 is a constitutively expressed enzyme in most mammalian tissues and maintains normal cellular physiological functions, such as platelet aggregation and gastric cytoprotection; while cyclooxygenase-2 is normally expressed at a very low level in most tissues and is highly inducible by growth factors, cytokines, and tumour promoters. In several studies, the effect of cyclooxygenases on different cell types has been investigated. This review focuses on cyclooxygenases function, cell proliferation and differentiation.

 

Key words: Cyclooxygenases, proliferation, differentiation, prostaglandins, tumor.